Determining eligibility for antiretroviral therapy in resource-limited settings using total lymphocyte counts, hemoglobin and body mass index

[1]  Michael S Saag,et al.  Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society--USA panel. , 2006, Topics in HIV medicine : a publication of the International AIDS Society, USA.

[2]  Orc Macro,et al.  Uganda HIV/AIDS Sero-Behavioural Survey 2004-2005 , 2006 .

[3]  R. Quick,et al.  Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda , 2004, The Lancet.

[4]  U. Lalloo,et al.  Application of an algorithm to predict CD4 lymphocyte count below 200 cells/mm(3) in HIV-infected patients in South Africa. , 2004, AIDS.

[5]  D. Legros,et al.  Indirect markers to initiate highly active antiretroviral therapy in a rural African setting. , 2004, AIDS.

[6]  G. Maartens,et al.  Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa , 2004, AIDS.

[7]  G. Friedland,et al.  Use of total lymphocyte count for monitoring response to antiretroviral therapy. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  Richard D Moore,et al.  Total lymphocyte count and hemoglobin combined in an algorithm to initiate the use of highly active antiretroviral therapy in resource‐limited settings , 2003, AIDS.

[9]  J. Kahn,et al.  Absolute or total lymphocyte count as a marker for the CD4 T lymphocyte criterion for initiating antiretroviral therapy. , 2003, AIDS.

[10]  R. Wood,et al.  Usefulness of total lymphocyte count in monitoring highly active antiretroviral therapy in resource-limited settings , 2003, AIDS.

[11]  T. Flanigan,et al.  Total Lymphocyte Count (TLC) Is a Useful Tool for the Timing of Opportunistic Infection Prophylaxis in India and Other Resource‐Constrained Countries , 2002, Journal of acquired immune deficiency syndromes.

[12]  P. Weidle,et al.  Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance , 2002, The Lancet.

[13]  F. Liégeois,et al.  The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study , 2002, AIDS.

[14]  B. Yip,et al.  Total Lymphocyte Count as a Possible Surrogate of Cd4 Cell Count to Prioritize Eligibility for Antiretroviral Therapy among HIV-Infected Individuals in Resource-Limited Settings , 2002, Antiviral therapy.

[15]  Julio S. G. Montaner,et al.  Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy. , 2001, JAMA.

[16]  G. Maartens,et al.  CD4 and total lymphocyte counts as predictors of HIV disease progression. , 1996, QJM : monthly journal of the Association of Physicians.

[17]  M. Edwardes,et al.  Confidence intervals for a binomial proportion by S. E. Vollset, Statistics in Medicine, 12, 809-824 (1993) , 1994, Statistics in medicine.

[18]  S E Vollset,et al.  Confidence intervals for a binomial proportion. , 1994, Statistics in medicine.

[19]  M. Schechter,et al.  Predicting CD4 counts in HIV-infected Brazilian individuals: a model based on the World Health Organization staging system. , 1994, Journal of Acquired Immune Deficiency Syndromes.

[20]  Michael S Saag,et al.  Treatment for Adult HIV Infection 2006 Recommendations of the International AIDS Society–USA Panel , 2006 .

[21]  James Curran,et al.  Scaling Up Antiretroviral Therapy in Resource-Limited Settings: Treatment Guidelines for a Public Health Approach , 2005 .